After multivariate linear regression analyses, Q1 had a higher NIHSS score than Q4 (P=0.010). The Figure shows the distribution of mRS scores. No patients in Q1 had mRS score 0 to 1, as compared with other quartiles (P<0.001). Patients with mRS score 0 to 2 were less frequent in Q1 than Q4 as crude values (P=0.002) and after adjustment with risk factors and comorbidities (P=0.026), but they were no longer different after additional adjustment with hematoma volume and NIHSS score (Table 2) . Patients with mRS score 5 to 6 and those with fatal outcomes were more frequent in Q1 than Q4 as crude values (P=0.016 and 0.048, respectively), but the difference disappeared after multivariate adjustment (Table III in 
I
ntracerebral hemorrhage (ICH) is associated with poor outcome, a high mortality rate, and little effective treatment. 1 In patients with acute ICH, large hematoma volume, the presence of intraventricular bleeding, and prior use of anticoagulants or antiplatelets are reported to be associated with poor outcome. 2, 3 Several studies have reported that low serum calcium (Ca) levels have an association with large infarcts and poor outcome among patients with ischemic stroke. [4] [5] [6] In another study involving a majority of patients with ischemic stroke and few patients with ICH, low serum Ca levels were also associated with poor outcome. 7 In addition, ionized Ca is an essential cofactor for the coagulation cascade and associated with conversion of prothrombin to thrombin. Association of Ca levels with changes in clotting time and bleeding tendency was shown in the rodent models. 8, 9 Thus, serum Ca levels might play a pivotal role in hemostasis in acute ICH.
However, associations of serum Ca levels with clinical findings and outcomes of isolated patients with ICH remain unknown. Thus, the aim of the present study was to examine the associations between admission Ca levels and clinical findings and outcomes in patients with acute ICH.
Patients and Methods
Consecutive patients admitted to our department within 24 hours from the onset of nontraumatic ICH were studied using our prospectively collected database on inpatients with stroke. Patients were classified into quartiles based on admission serum Ca levels (Q1 [≤9.0], Q2 [9.1-9.3], Q3 [9.4-9.7] , Q4 [≥9.8] mg/dL). Acute outcomes included the following: the National Institutes of Health Stroke Scale (NIHSS) score at admission, initial hematoma volume, and hematoma growth. Chronic outcomes included the following: modified Rankin Scale (mRS) scores of 0 to 1 and 0 to 2, bedridden state or death corresponding to mRS scores of 5 to 6 at 30 days, and mortality. For chronic outcomes, patients with prestroke mRS score ≥2 were excluded from the analyses. Associations between each Ca quartile and outcomes were determined using multivariate regression models adjusted by the baseline characteristics automatically selected in a backward stepwise selection method (see Methods in the onlineonly Data Supplement).
Results
A total of 273 patients (92 women, 70±11 years old) were studied. There were fewer women (P=0.036), liver dysfunction was more common (P=0.043), and levels of albumin (P<0.001), total cholesterol (P=0.002), low-density lipoprotein-cholesterol (P<0.001), high-density lipoproteincholesterol (P=0.027), and hemoglobin (P=0.002) were lower in the lower Ca level quartiles than in the higher Ca level quartiles (see Tables I and II in the online-only Data  Supplement) .
The lowest Ca quartile had higher hematoma volume (P=0.005; Table 1 ). After multivariate linear regression analyses, Q1 had larger hematoma volume than Q4 (P=0.015). The lowest Ca quartile had a higher NIHSS score (P=0.010).
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After multivariate linear regression analyses, Q1 had a higher NIHSS score than Q4 (P=0.010). The Figure shows the distribution of mRS scores. No patients in Q1 had mRS score 0 to 1, as compared with other quartiles (P<0.001). Patients with mRS score 0 to 2 were less frequent in Q1 than Q4 as crude values (P=0.002) and after adjustment with risk factors and comorbidities (P=0.026), but they were no longer different after additional adjustment with hematoma volume and NIHSS score ( Table 2) . Patients with mRS score 5 to 6 and those with fatal outcomes were more frequent in Q1 than Q4 as crude values (P=0.016 and 0.048, respectively), but the difference disappeared after multivariate adjustment (Table III in 
Discussion
This is the first study that investigated the relationships between serum Ca levels at admission and clinical findings and outcomes of patients with acute ICH. The major new finding was that patients with low Ca levels had larger hematoma volumes and higher NIHSS scores at admission.
Three possible mechanisms may explain why serum Ca levels are related to severity at admission. First, as stated above, ionized Ca is an essential cofactor for the coagulation cascade. Second, low serum Ca levels might contribute to hematoma enlargement through blood pressure elevation in the acute ICH. Ca was reported to induce relaxation of isolated arteries by activating Ca receptors in perivascular nerves. 10 Third, low serum Ca levels might reflect poor liver function. The lowest Ca quartile (Q1) had high percentage of liver disease, and these findings suggested another mechanism for poor coagulation and therefore larger hematoma volume.
This study was limited by its design as a single-center, hospital-based, retrospective analysis with exclusion of some patients attributable to lack of serum Ca level data. To simplify reporting of results, data on ionized Ca levels and albumin-corrected Ca levels were not shown. Instead, the serum albumin level was used for multivariate regression analyses and it did not affect the results.
In conclusion, low Ca levels in the hyperacute stage of ICH are indicators of larger hematoma volume and more severe neurological deficit. There is an apparent association between serum Ca levels and hematoma volume. Future studies could incorporate serum Ca in models and test for enhanced 
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CT imaging and image analysis
ICH was verified by emergent computed tomography (CT) immediately after hospital arrival. Follow-up CT was performed routinely within 24 hours after admission.
Hematoma location and the presence of intraventricular bleeding were recorded on initial CT scan. Hematoma volumes were measured using the ABC/2 method. was not included in volume calculations. All CT scans were reviewed and evaluated by two trained stroke specialists who were blinded to the patients' clinical status.
Data collection
Baseline clinical and demographic information included age, sex, history of ischemic stroke or prior ICHs, premorbid modified Rankin Scale (mRS) score, liver dysfunction (cirrhosis or chronic hepatitis on history), hypertension, diabetes mellitus, dyslipidemia, history of alcohol or tobacco use, and prestroke use of anticoagulants, antiplatelet agents, antihypertensive agents, and statins. Body mass index and blood pressure (BP) levels on admission were also documented. The time of ICH onset was defined as the time when the patient was last known to be normal if the exact time of acute onset of a neurological deficit could not be clearly specified.
Blood tests were performed at the time of admission before any crystalloid infusion therapy. Laboratory results, including Ca and the variables listed in Table 2 , were recorded, and the estimated glomerular filtration rate (eGFR) was calculated. 
Outcomes
As acute outcome measures, the National Institutes of Health Stroke Scale (NIHSS) score on admission evaluated by stroke experts, initial hematoma volume, and hematoma growth were assessed. Chronic outcomes were evaluated at 30 days; independence corresponding to mRS scores of 0-1 and 0-2, bedridden state or death corresponding to mRS scores of 5-6, and mortality were assessed. For chronic outcomes, 18 patients with prestroke mRS score ≥2 were excluded from the analyses.
Statistical analysis
Baseline demographics and clinical characteristics were compared across quartiles by serum Ca levels using the χ 2 test for percentages and the Kruskal-Wallis rank-sum test for medians.
Continuous variables are reported as medians (interquartile range) unless stated otherwise.
Fisher's exact test was used to compare dichotomous variables between groups, and the Wilcoxon rank-sum test was used for continuous and ordinal variables. The difference in each quartile of serum Ca levels compared to the highest quartile of Ca levels (Q4) was measured in relation to hematoma volume, NIHSS score on admission, and outcomes.
Hematoma volume and NIHSS score on admission were log-transformed to approximate normality. Multivariate linear regression analyses for hematoma volume and NIHSS score on admission and multivariate logistic regression analyses for 30-day outcomes were performed by adjusting for sex, age, and variables that were automatically selected in a backward stepwise selection method. A backward selection procedure was performed for each outcome using p>0.10 of the likelihood ratio test for exclusion. The odds ratio and 95% CI were Abbreviation: LDL-Cho, low-density-lipoprotein cholesterol; HDL-Cho, high-density-lipoprotein cholesterol; hs-CRP, high sensitive C-reactive protein; aPTT, activated partial thromboplastin time;
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PT-INR, prothrombin time-international normalized ratio; e-GFR, estimated glomerular filtration rate Adjusted by age, sex, liver dysfunction, prestroke antiplatelet use, systolic blood pressure, albumin, hemoglobin, and platelet count in "Death".
Model 2:
Adjusted by variables in Model 1 plus NIHSS score on admission and hematoma volume.
